Roche's TaqMan PCR promises faster results:
This article was originally published in Clinica
Executive Summary
Roche says that a first analysis of a prototype Chlamydia test run on its COBAS TaqMan 48 PCR analyser has shown that the instrument can improve overall throughput and enhance overall laboratory operational efficiency. According to the Basel, Switzerland-based company, it was possible to detect 48 processed patient samples in just 2.5 hours using the TaqMan instrument, whereas detecting the same 48 samples on the firm's Cobas Amplicor instrument might take as long as 6.5 hours. The results also showed the Taq-based test to be comparable in sensitivity and specificity to current nucleic acid amplification testing technologies.